Posted 15 ноября 2022,, 07:27

Published 15 ноября 2022,, 07:27

Modified 24 декабря 2022,, 22:38

Updated 24 декабря 2022,, 22:38

In Moscow, pharmacies have doubled the permitted prices for Ozempik, a drug for diabetes

In Moscow, pharmacies have doubled the permitted prices for Ozempik, a drug for diabetes

15 ноября 2022, 07:27
Фото: 1MI
About 30 Moscow pharmacies sell Ozempik, a type 2 diabetes drug manufactured by the Danish company Novo Nordisk, at a price 2-3 times higher than the maximum registered price.
Moscow region

This follows from the data of the online help. In pharmacies offered in the application of the federal system of mandatory labeling "Honest Sign", in particular, in the chains "Capital", "Neo-Pharm" and "Pharmacy Ave" - there is no "Ozempik" at all, writes RBC.

This medicine is included in the list of vital and essential medicines for this year. The maximum registered price for it is 5.8 thousand rubles. In retail, the maximum price should not exceed 7.7 thousand rubles, including VAT. But Europharm and LekarPharm sell the drug for 16,000 rubles, and MedZdrava sells it for 23,000 rubles per pack of 1.5 ml.

The FAS forwarded the question to Roszdravnadzor, and they said that the overpricing of the selling price is a violation, and this fact will be checked.

According to experts, the simultaneous overpricing of the drug and its disappearance from a number of pharmacies indicates the existence of an illegal scheme for the drug to enter the market. Probably, we are talking about repurchasing Ozempic in the “white” retail at a low price or from patients who purchased it under preferential prescriptions.

At the beginning of the month, the Ministry of Industry and Trade confirmed the shortage of broad-spectrum antibiotics, including amoxiclav, in pharmacies and explained that the reason was partial mobilization. At the same time, at first, the department indicated that the shortage was the result of increased demand for the drug due to a seasonal rise in the incidence, as well as the fact that citizens buy medicines “in reserve”, despite the fact that the drug is prescription.